Agios Pharmaceuticals to Present at the 2014 Leerink Swann Global Healthcare Conference Read more about Agios Pharmaceuticals to Present at the 2014 Leerink Swann Global Healthcare Conference
Agios Pharmaceuticals Exercises Option to U.S. Development and Commercialization Rights for IDH1 Program under Celgene Collaboration Read more about Agios Pharmaceuticals Exercises Option to U.S. Development and Commercialization Rights for IDH1 Program under Celgene Collaboration
Agios Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference Read more about Agios Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference
Agios Pharmaceuticals Added to NASDAQ Biotechnology Index Read more about Agios Pharmaceuticals Added to NASDAQ Biotechnology Index
Agios Advances Cancer Metabolism Collaboration with Celgene Read more about Agios Advances Cancer Metabolism Collaboration with Celgene
Agios Presents Preclinical Data from Lead Programs at American Society of Hematology Annual Meeting Read more about Agios Presents Preclinical Data from Lead Programs at American Society of Hematology Annual Meeting
Agios Pharmaceuticals to Present Preclinical Research at the 2013 American Society of Hematology Annual Meeting Read more about Agios Pharmaceuticals to Present Preclinical Research at the 2013 American Society of Hematology Annual Meeting
Agios Pharmaceuticals Reports Third Quarter 2013 Financial Results Read more about Agios Pharmaceuticals Reports Third Quarter 2013 Financial Results
Agios Pharmaceuticals to Webcast Conference Call Discussing Third Quarter 2013 Financial Results on November 7, 2013 Read more about Agios Pharmaceuticals to Webcast Conference Call Discussing Third Quarter 2013 Financial Results on November 7, 2013
Agios to Present IDH Program Insights at AACR-NCI-EORTC International Conference Read more about Agios to Present IDH Program Insights at AACR-NCI-EORTC International Conference